HP
UTHR icon

Hikari Power’s United Therapeutics UTHR Stock Holding History

Hikari Power’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,300
Closed -$270K – 140
2019
Q1 		$270K Hold
2,300
– – 0.03% 105
2018
Q4 		$250K Hold
2,300
– – 0.03% 100
2018
Q3 		$294K Hold
2,300
– – 0.03% 97
2018
Q2 		$260K Sell
2,300
-9,190
-80% -$1.01M 0.03% 108
2018
Q1 		$1.29M Hold
11,490
– – 0.15% 58
2017
Q4 		$1.7M Hold
11,490
– – 0.2% 48
2017
Q3 		$1.35M Hold
11,490
– – 0.17% 54
2017
Q2 		$1.49M Sell
11,490
-8,410
-42% -$1.05M 0.2% 47
2017
Q1 		$2.69M Hold
19,900
– – 0.38% 36
2016
Q4 		$2.85M Sell
19,900
-4,200
-17% -$536K 0.41% 36
2016
Q3 		$2.85M Buy
+24,100
New +$2.9M 0.34% 49

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Hikari Power's UTHR Position: Q2 2019 in Review

Hikari Power sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 2,300 shares — an estimated $270K sold.

Hikari Power first reported a position in UTHR in Q3 2016 and held it in 11 quarters. The position peaked at $2.85M in Q4 2016. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • Hikari Power reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Hikari Power sold 2,300 United Therapeutics shares in Q2 2019, an estimated $270K.
  • Hikari Power first reported a position in United Therapeutics in Q3 2016 and held it in 11 quarters.
  • Hikari Power's United Therapeutics position peaked at $2.85M in Q4 2016.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Hikari Power's 13F filing for Q2 2019, filed 8 Aug 2019.